Clinical Trial Update: Carvedilol and Midodrine Versus Carvedilol Alone in Preventing Early Rebleed in Patients With Cirrhosis. [NA]

View source ↗

Summary

A clinical trial comparing carvedilol plus midodrine versus carvedilol alone to prevent early rebleed in patients with liver cirrhosis; the study status is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Cirrhosis

Drugs mentioned

• CARVEDILOL (Carvedilol)
• Midodrine (Midodrine)

Snippet

Sponsor: Institute of Liver and Biliary Sciences, India | Conditions: Liver Cirrhosis | NA | Status: NOT_YET_RECRUITING